Aquilo Capital Management’s Zymeworks ZYME Stock Holding History

Aquilo Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-84,482	Closed	-$1.01M	–	13
2025 Q1	$1.01M	Buy	+84,482	New	+$1.15M	1.8%	13

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Aquilo Capital Management's ZYME Position: Q2 2025 in Review

Aquilo Capital Management sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 84,482 shares — an estimated $1.01M sold.

Aquilo Capital Management first reported a position in ZYME in Q1 2025 and held it in 1 quarter. The position peaked at $1.01M in Q1 2025. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

Aquilo Capital Management reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
Aquilo Capital Management sold 84,482 Zymeworks shares in Q2 2025, an estimated $1.01M.
Aquilo Capital Management first reported a position in Zymeworks in Q1 2025 and held it in 1 quarter.
Aquilo Capital Management's Zymeworks position peaked at $1.01M in Q1 2025.
181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Aquilo Capital Management's 13F filing for Q2 2025.